Stock Events

Stock Events

Co-Diagnostics 

$1.1900
116
+$0.04+3.48% 18:15 Today

Statistics

Day High
1.23
Day Low
1.13
52W High
46.5
52W Low
0.94
Volume
256,158
Avg. Volume
2,069,516
Mkt Cap
8.31M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-5.7
-3.88
-2.05
-0.23
Expected EPS
-1.25
Actual EPS
N/A

Financials

-7,539.55%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
622,000Revenue
-46.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CODX. It's not an investment recommendation.
Tesla
22
TSLA
Apple
21
AAPL
Microsoft
21
MSFT
Amazon
21
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Qiagen NV
QGEN
Mkt Cap8.87B
QIAGEN offers diagnostic solutions, including molecular diagnostics which directly compete with Co-Diagnostics' testing technologies.
Thermo Fisher Scientific
TMO
Mkt Cap217.52B
Thermo Fisher Scientific provides a broad range of diagnostic and research products, including molecular diagnostics that compete with CODX offerings.
Bio-Rad Laboratories
BIO
Mkt Cap9.53B
Bio-Rad Laboratories offers a variety of diagnostic tests and systems, including PCR-based tests, which are in direct competition with Co-Diagnostics' products.
Quest Diagnostics
DGX
Mkt Cap25.87B
Quest Diagnostics provides diagnostic testing services, including molecular diagnostics, competing with Co-Diagnostics in the laboratory testing market.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America offers a wide range of diagnostic tests, including molecular diagnostics, making it a competitor in the diagnostics market.
Abbott Laboratories
ABT
Mkt Cap192.51B
Abbott Laboratories offers a broad portfolio of diagnostic products, including molecular diagnostics, competing across several of Co-Diagnostics' market segments.
Agilent Technologies
A
Mkt Cap41.95B
Agilent Technologies provides life sciences, diagnostics, and applied chemical markets with instruments and services, including diagnostics that compete with Co-Diagnostics.
Baxter International
BAX
Mkt Cap13.82B
Baxter International offers a range of medical devices and laboratory equipment, some of which are used in diagnostic applications that compete with Co-Diagnostics.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, including molecular diagnostics, making it a significant competitor to Co-Diagnostics in the global diagnostics market.

About

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Show more...
CEO
Dwight Egan
Employees
115
Country
United States
ISIN
US1897632048
WKN
000A41UNJ

Listings

STU
DE
C970.STU
STU
DE
C97.STU
MU
DE
C970.MU
LSE
GB
0A50.LSE

0 Comments

Share your thoughts

FAQ

What is Co-Diagnostics stock price today?▼
The current price of CODX is $1.19 USD — it has increased by +3.48% in the past 24 hours. Watch Co-Diagnostics stock price performance more closely on the chart.
What is Co-Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Co-Diagnostics stocks are traded under the ticker CODX.
Is Co-Diagnostics stock price growing?▼
CODX stock has fallen by -15% compared to the previous week, the month change is a -49.58% fall, over the last year Co-Diagnostics has showed a -87.08% decrease.
What is Co-Diagnostics market cap?▼
Today Co-Diagnostics has the market capitalization of 8.31M
When is the next Co-Diagnostics earnings date?▼
Co-Diagnostics is going to release the next earnings report on November 05, 2026.
What were Co-Diagnostics earnings last quarter?▼
CODX earnings for the last quarter are -1.46 USD per share, whereas the estimation was -3 USD resulting in a +51.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Co-Diagnostics revenue for the last year?▼
Co-Diagnostics revenue for the last year amounts to 622,000 USD.
What is Co-Diagnostics net income for the last year?▼
CODX net income for the last year is -46.9M USD.
How many employees does Co-Diagnostics have?▼
As of August 21, 2026, the company has 115 employees.
In which sector is Co-Diagnostics located?▼
Co-Diagnostics operates in the Health & Wellness sector.
When did Co-Diagnostics complete a stock split?▼
The last stock split for Co-Diagnostics was on January 02, 2026 with a ratio of 1:30.
Where is Co-Diagnostics headquartered?▼
Co-Diagnostics is headquartered in SALT LAKE CITY, United States.